Gilead Sciences
GILD
#110
Rank
C$252.77 B
Marketcap
C$203.85
Share price
0.49%
Change (1 day)
31.85%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): C$10.24

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is C$10.34. In 2025 the company made an earnings per share (EPS) of C$9.54 an increase over its 2024 EPS that were of C$0.53.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$10.247.26%
2025C$9.541702.63%
2024C$0.53-91.65%
2023C$6.3423.98%
2022C$5.11-25.86%
2021C$6.904850%
2020C$0.14-97.64%
2019C$5.910.9%
2018C$5.8618.71%
2017C$4.93-64.88%
2016C$14.05-18.45%
2015C$17.2255.28%
2014C$11.09296.02%
2013C$2.8017.89%
2012C$2.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.17 17.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.83-82.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.87-72.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$39.33 280.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.18 95.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$13.03 26.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$7.71-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$23.70 129.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$4.98-51.82%๐Ÿ‡บ๐Ÿ‡ธ USA